Search Result "T315I"

Export

Inhibitors of ABL and the ABL-T315I Mutation

Journal: Current Topics in Medicinal Chemistry

Volume: 8 Issue: 1 Year: 2008 Page: 905-921

Author(s): Glenn Noronha, Jianguo Cao, Chun P. Chow, Elena Dneprovskaia, Richard M. Fine, John Hood, Xinshan Kang, Boris Klebansky, Dan Lohse, Chi Ching Mak, Andrew McPherson, Moorthy S.S. Palanki, Ved P. Pathak, Joel Renick, Richard Soll, Binqi Zeng

Recent Developments in the Third Generation Inhibitors of Bcr-Abl for Overriding T315I Mutation

Journal: Current Medicinal Chemistry

Volume: 18 Issue: 1 Year: 2011 Page: 2146-2157

Author(s): X. Y. Lu, Q. Cai, K. Ding

Research Article
Screening and Activity Evaluation of Novel BCR-ABL/T315I TyrosineKinase Inhibitors

Journal: Current Medicinal Chemistry

Volume: 31 Issue: 20 Year: 2024 Page: 2872-2894

Author(s):

Second Generation Abl Kinase Inhibitors and Novel Compounds to Eliminate the Bcr-Abl/T315I Clone

Journal: Recent Patents on Anti-Cancer Drug Discovery

Volume: 1 Issue: 3 Year: 2006 Page: 347-355

Author(s): Shinya Kimura

Research Article
3D-QSAR Studies on New Benzothiazole-Based Dual Functional Inhibitors of BCR-ABL Kinase Including the T315I Mutant

Journal: Letters in Drug Design & Discovery

Volume: 15 Issue: 10 Year: 2018 Page: 1046-1056

Author(s): Shunlai Li,Chaorui Ren,Chenghu Lu,Xiuxiu Li,Hongguang Du

Research Article open access plus
Mutation Analysis of ABL1 Gene and its Relation to the Achievement of Major Molecular Response in Indonesian Chronic Myeloid Leukemia Patients

Journal: Current Pharmacogenomics and Personalized Medicine

Volume: 17 Issue: 1 Year: 2020 Page: 48-54

Author(s): Reni Widyastuti,Melva Louisa,Ikhwan Rinaldi,Riki Nova,Instiaty Instiaty,Rizky Priambodo

New Opportunities to Treat the T315I-Bcr-Abl Mutant in Chronic Myeloid Leukaemia: Tyrosine Kinase Inhibitors and Molecules that Act by Alternative Mechanisms

Journal: Current Medicinal Chemistry

Volume: 17 Issue: 1 Year: 2010 Page: 1220-1245

Author(s): S. Schenone, C. Brullo, M. Botta

Review Article
Ponatinib: A Review of Efficacy and Safety

Journal: Current Cancer Drug Targets

Volume: 18 Issue: 9 Year: 2018 Page: 847-856

Author(s): Fulvio Massaro,Matteo Molica,Massimo Breccia

Targeting Drug Resistant Mutations Using Novel Binding Interactions – Lessons Learned from Abl-T315I and their Implications in Drug Design

Ebook: Frontiers in Drug Design and Discovery

Volume: 3 Year: 2007

Author(s): Glen Noronha,Jianguo Cao,Chun Chow,Elena Dneprovskaia,Linda Hwang,Dan Lohse,Chi Ching Mak,Andrew McPherson,Richard M. Fine,Xinshan Kang,Boris Klebansky,Moorthy S.S. Palanki,Ved P. Pathak,Joel Renick,Richard Soll,Binqi Zeng

Doi: 10.2174/978160805201110703010121

Previous   Next

Go to   Results 1 - 1 of 194
Volume Years
Article Type
Publication Title
Subject Title
Content Type